Skip to main content
OpenTrials
Completed

NCT Number: NCT01169896

Impact of Ventricular Pacing in Unselected ICD/CRT-D Patients

Observational study is evaluating Ventricular Tachycardia (VT)/Ventricular Fibrillation (VF) thérapies as a function of ventricular pacing

Completed

Looking for future studies?

Notify Me

Key information

About this study

This protocol consists in a non-interventional multi-centre, prospective study. The observational study will also answer the question of the impact of ventricular pacing on the outcome of patients implanted with ICD & CRT-D devices and how the ICD & CRT-D devices are used in clinical practice through two years follow-up.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Main inclusion Criteria:

•Patient implanted (primo implantation or replacement) with an ICD (OVATIO VR 6250, DR 6550, CRT 6750 models, or any similar or higher range device, that includes specific diagnostic and therapeutic functionalities, mandatory to make homogeneous the collection of data)

Main exclusion Criteria:

  • Presence of a contra-indication to the ICD therapy.
  • Life expectancy less than 12 months.

Treatment and study plan

Primary outcomes

  1. VT/VF episodes according to ventricular pacing (> and <50%)

    Time frame: 2 years

    Device-based data

Sponsors and collaborators

Lead sponsor

LivaNova

Industry

Registry information

Acronym: FIRST

Important dates

Study start
2007
Primary completion
2011
Study completion
2011
First posted
Jul 26, 2010
Registry last updated
Dec 3, 2015

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.